Boiled Peanut Powder for Peanut Hypersensitivity

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Peanut Hypersensitivity+1 More
Boiled Peanut Powder - Drug
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether boiled peanuts can help treat peanut allergies in children, and whether the treatment is better than a placebo.

Eligible Conditions
  • Peanut Hypersensitivity

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 18 weeks

18 weeks
Increase in tolerance to peanut in pediatric patients with peanut hypersensitivity.

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Boiled Peanut Powder
1 of 1
Experimental Treatment

10 Total Participants · 1 Treatment Group

Primary Treatment: Boiled Peanut Powder · No Placebo Group · Phase 1

Boiled Peanut Powder
Drug
Experimental Group · 1 Intervention: Boiled Peanut Powder · Intervention Types: Drug

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 18 weeks

Who is running the clinical trial?

The Cleveland ClinicOTHER
940 Previous Clinical Trials
1,407,332 Total Patients Enrolled
Alton MeltonLead Sponsor
Jaclyn Bjelac, MDPrincipal InvestigatorStaff

Eligibility Criteria

Age < 18 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 10th, 2021

Last Reviewed: October 21st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.